The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Human fetal liver derived stem cell transplantation as supportive modality in the management of end stage decompensated liver cirrhosis
Open accessAbstract
Liver transplantation is the only existing modality for treating decompensated liver cirrhosis. Several factors, such as nonavailability of donors, combined with operative risks, complications associated with rejection, usage of immunosuppressive agents, and cost intensiveness, make this strategy available to only a few people. With a tremendous upsurge in the mortality rate of patients with liver disorders worldwide, there is a need to search for an alternative therapeutic tool that can combat the above limitations and serve as a supportive therapy in the management of liver diseases. Cell therapy using human fetal liver-derived stem cells can provide great potential to conservatively manage end-stage liver diseases. Therefore, the present investigation aimed to study and prove the safety and efficacy of human fetal liver-derived stem cell transplantation in patients with end-stage liver cirrhosis. Twenty-five patients with liver cirrhosis of different etiologies were infused with human fetal liver-derived stem cells (EpCAM+ve) labeled with Tc-HMPAO through hepatic artery. Our high throughput analysis using flow cytometry, RT-PCR, and cellular characterization exemplifies fetal liver cells with their high proliferation rate could be the best source for rejuvenating the diseased liver. Further, no episodes related to hepatic encephalopathy recurred in any of the subjects following hepatic stem cell transplantation. There was marked clinical improvement observed in terms of all clinical and biochemical parameters. Further, there was decrease in mean MELD score (p < 0.01) observed in 6 months follow-up in all patients. Therapy using human fetal liver stem/progenitor cells offers a potentially supportive modality to organ transplantation in the management of liver diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When the proliferation of liver parenchymal cells is hampered, especially in advanced fibrosis, LPCs may become activated and differentiate into mature hepatocytes and cholangiocytes, thereby facilitating repopulation and improving liver function [20, 41].”
From Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells (2025) · cites this paper as [20]
In the citing paper
“In a clinical trial, 25 patients with MELD scores exceeding 16 were infused with human fetal liver-derived EpCAM+ LPCs through the hepatic artery [20]. The six-month follow-up period revealed no complications related to the procedure while demonstrating significant improvements in MELD scores and levels of serum ALB, alkaline phosphatase (ALP), and bilirubin.”
From Mechanisms, efficacy, and future perspectives of cellular-based therapies for liver fibrosis/cirrhosis: focusing on mesenchymal stromal cells (2025) · cites this paper as [20]
Citations
Cites
Liver regeneration and repair: Hepatocytes, progenitor cells, and stem cells
Fausto, N. (2004) · Hepatology · doi:10.1002/hep.20214 · Cited by 720
The canals of hering and hepatic stem cells in humans
Theise, N. D., Saxena, R., Portmann, B. C., Thung, S. N., Yee, H. T., Chiriboga, L. A., Kumar, A., & Crawford, J. M. (1999) · Hepatology · doi:10.1002/hep.510300614 · Cited by 700
Human hepatic stem cells from fetal and postnatal donors
Schmelzer, E., Zhang, L., Bruce, A., Wauthier, E., Ludlow, J. W., Yao, H.-L., Moss, N., Melhem, A., McClelland, R., Turner, W. S., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061603 · Cited by 585
The origin and liver repopulating capacity of murine oval cells
Wang, X., Foster, M., Al-Dhalimy, M., Lagasse, E., Finegold, M., & Grompe, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1734199100 · Cited by 410
Cell lineages and oval cell progenitors in rat liver development.
Shiojiri, N., Lemire, J. M., & Fausto, N. (1991) · PubMed · Cited by 385
Suzuki, A., Zheng, Y.-W., Kaneko, S., Onodera, M., Fukao, K., Nakauchi, H., & Taniguchi, H. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108066 · Cited by 356
The Phenotypes of Pluripotent Human Hepatic Progenitors
Schmelzer, E., Wauthier, E., & Reid, L. M. (2006) · Stem Cells · doi:10.1634/stemcells.2006-0036 · Cited by 333
HUMAN FETAL HEPATOCYTE TRANSPLANTATION IN PATIENTS WITH FULMINANT HEPATIC FAILURE
Habibullah, C. M., Syed, I. H., Qamar, A., & Taher-Uz, Z. (1994) · Transplantation · doi:10.1097/00007890-199410270-00016 · Cited by 301
Self-citationDan, Y. Y., Riehle, K. J., Lázaro, C. A., Teoh, N., Haque, J. A., Campbell, J. S., & Fausto, N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603824103 · Cited by 300
KUBOTA, H. Y., & Reid, L. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.12132 · Cited by 242
Cited by
Sorted by citations
Human hepatocyte transplantation for liver disease: current status and future perspectives
Iansante, V, Mitry, R. R., Filippi, C., Fitzpatrick, E., & Dhawan, A. (2018) · Pediatric Research · doi:10.1038/pr.2017.284 · Cited by 225
The biliary tree—a reservoir of multipotent stem cells
Cardinale, V., Wang, Y., Carpino, G., Mendel, G., Alpini, G. D., Gaudio, E., Reid, L. M., & Alvaro, D. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.23 · Cited by 207
Zagoura, D., Roubelakis, M. G., Bitsika, V., Trohatou, O., Pappa, K. I., Kapelouzou, A., Antsaklis, A., & Anagnou, N. P. (2011) · Gut · doi:10.1136/gutjnl-2011-300908 · Cited by 182
Hematopoietic Stem Cells and Their Roles in Tissue Regeneration
Lee, J. Y., & Hong, S.-H. (2020) · International Journal of Stem Cells · doi:10.15283/ijsc19127 · Cited by 165
Orlando, G., Baptista, P. M., Birchall, M., Coppi, P. D., Farney, A. C., Guimarães-Souza, N., Opara, E. C., Rogers, J. D., Seliktar, D., Shapira‐Schweitzer, K., et al. (2010) · Transplant International · doi:10.1111/j.1432-2277.2010.01182.x · Cited by 168
Metadata
- Authors
- Khan, A. A., Shaik, M. V., Parveen, N., Rajendraprasad, A., Aleem, M. A., Aejaz, M., Srinivas, G., Avinash, T., Tiwari, S. K., Kumaresan, K., Venkateswarlu, J., Pande, G., & Habibullah, C.
- Affiliations
- Deccan College of Medical Sciences (IN)
- Centre for Cellular and Molecular Biology (IN)
- Venue
- Cell Transplantation
- Publisher
- SAGE Publications
- Published
- 2010
- Volume
- 19
- Issue
- 4
- Pages
- 409-418
- ISSN
- 0963-6897 (ISSN-L)
- OpenAlex
- W2078785430
- Cited by
- 183
- References
- 35
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 3 · 2023: 7 · 2022: 7 · 2021: 8 · 2020: 9 · 2019: 14 · 2018: 13 · 2017: 11 · 2016: 15 · 2015: 12 · 2014: 20 · 2013: 17 · 2012: 18
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- green
- doaj.org
- Licence
- cc-by-sa
- Locations
- Cell Transplantation (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- stem cell transplantation, decompensated cirrhosis, end-stage liver disease, hepatic artery infusion, hepatic encephalopathy, MELD score, cell therapy, liver regeneration, supportive therapy
- MeSH terms
- Adult, Flow Cytometry, Humans, Liver, Liver Cirrhosis, Male, Middle Aged, Severity of Illness Index, Biomarkers, Technetium Tc 99m Exametazime, Stem Cell Transplantation, Fetal Stem Cells, Cell- and Tissue-Based Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
